Call Us: 0049-(0)-9131-85-0 or Write Us: closed @ uk-erlangen.de
Clonidine for Sedation of Paediatric Patients in the Intensive Care Unit

Objectives

CloSed comprises four main objectives:

1. To develop an age-appropriate intravenous clonidine formulation at 3 different strengths in order to accurately administer the drug based on dose per volume and patient weight

2. To generate safety and efficacy data on clonidine in children and adolescents from birth to <18 years

3. To use the project results to apply for a Paediatric Use Marketing Authorisation (PUMA)

4. To develop guidelines for sedation of critically ill newborns and children in the Paediatric Intensive Care Unit (PICU) within the ESPNIC

CloSed is an EU-funded project

CloSed is an EU-funded project

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement n.602453

Sign up for the CloSed Project newsletter

In order to subscribe to the newsletter and receive news on the CloSed project activities please enter your email address below.
Back to Top